IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CATTANEO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.509
NA - Nord America 13.398
AS - Asia 12.743
SA - Sud America 1.225
AF - Africa 233
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 43.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.966
CN - Cina 4.497
GB - Regno Unito 4.327
SG - Singapore 3.504
IT - Italia 3.467
DE - Germania 2.054
SE - Svezia 1.294
HK - Hong Kong 1.220
RU - Federazione Russa 1.071
BR - Brasile 913
VN - Vietnam 801
IN - India 723
FR - Francia 699
NL - Olanda 484
KR - Corea 436
TR - Turchia 428
FI - Finlandia 405
UA - Ucraina 404
IE - Irlanda 341
BD - Bangladesh 334
CA - Canada 329
JP - Giappone 202
ID - Indonesia 189
EU - Europa 171
DK - Danimarca 156
ES - Italia 130
PL - Polonia 124
GR - Grecia 118
CO - Colombia 98
BE - Belgio 88
AR - Argentina 79
CH - Svizzera 66
CI - Costa d'Avorio 66
AU - Australia 62
MX - Messico 60
ZA - Sudafrica 54
NO - Norvegia 48
PH - Filippine 47
PK - Pakistan 45
IQ - Iraq 43
CZ - Repubblica Ceca 40
RO - Romania 40
AT - Austria 38
SA - Arabia Saudita 36
CL - Cile 33
EC - Ecuador 27
TW - Taiwan 25
PT - Portogallo 23
VE - Venezuela 23
NZ - Nuova Zelanda 20
EG - Egitto 19
JO - Giordania 19
TH - Thailandia 19
IL - Israele 18
MY - Malesia 18
PY - Paraguay 18
KE - Kenya 16
UZ - Uzbekistan 16
KZ - Kazakistan 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
MA - Marocco 14
PE - Perù 14
SC - Seychelles 13
TN - Tunisia 12
NP - Nepal 11
AL - Albania 9
BO - Bolivia 9
CR - Costa Rica 9
DZ - Algeria 9
AZ - Azerbaigian 8
HU - Ungheria 8
LU - Lussemburgo 8
OM - Oman 8
SK - Slovacchia (Repubblica Slovacca) 8
UY - Uruguay 8
GE - Georgia 7
HR - Croazia 7
BG - Bulgaria 6
BY - Bielorussia 6
EE - Estonia 6
JM - Giamaica 6
LV - Lettonia 6
MD - Moldavia 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
KG - Kirghizistan 5
LB - Libano 5
LT - Lituania 5
BA - Bosnia-Erzegovina 4
CG - Congo 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
MC - Monaco 4
MU - Mauritius 4
NG - Nigeria 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
Totale 43.301
Salva come PNG Salva come JPEG
Città #
Southend 3.693
Singapore 2.115
Milan 1.371
Chandler 1.138
Ashburn 1.135
Hong Kong 1.077
Beijing 873
San Jose 847
Seattle 635
Hanover 511
Fairfield 503
Shenzhen 502
Wilmington 475
Frankfurt am Main 472
Princeton 429
Dearborn 390
Council Bluffs 384
Dallas 380
Los Angeles 361
Dublin 338
Houston 327
Ann Arbor 310
Woodbridge 297
Santa Clara 281
New York 268
Jacksonville 252
Redmond 231
Ho Chi Minh City 228
Nanjing 205
Bengaluru 199
Hanoi 198
Guangzhou 195
Cambridge 187
Mountain View 187
Hangzhou 184
Lauterbourg 184
Helsinki 169
Shanghai 163
Hefei 158
Moscow 153
Boardman 142
Seoul 141
Des Moines 140
Buffalo 138
Munich 137
Sakarya 136
Jakarta 122
Berlin 120
Toronto 110
Redwood City 109
Tokyo 109
Phoenix 101
Athens 98
Sunnyvale 98
Rome 94
Jinan 88
São Paulo 88
Shenyang 85
Andover 84
Bogotá 84
Changsha 84
Warsaw 83
Ottawa 78
The Dalles 76
Columbus 73
Somerville 72
Tianjin 72
Cangzhou 69
Serra 68
Turin 68
Abidjan 66
Kent 66
Naples 63
Nanchang 61
Brussels 60
London 55
San Diego 54
Turku 53
Hebei 52
Istanbul 50
Fuzhou 49
Da Nang 48
Trento 47
Barcelona 46
Chicago 46
Atlanta 43
Falls Church 43
Washington 39
Amsterdam 38
Eitensheim 38
Wuhan 38
Bühl 37
Napoli 36
Nuremberg 36
Haiphong 35
Padova 35
San Francisco 35
Hamburg 34
Montreal 34
Mumbai 34
Totale 26.343
Salva come PNG Salva come JPEG
Nome #
The coding and long noncoding single-cell atlas of the developing human fetal striatum 1.224
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease 838
Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin 674
Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32(+) medium-sized spiny neurons 625
The Enigma of Huntington’s Disease 604
New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease 508
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 503
Proteasome activator enhances survival of huntington's disease neuronal model cells 489
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates 461
Human cortical organoids expose a differential function of GSK3 on cortical neurogenesis 457
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease 451
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease 389
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease 373
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes 372
Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease 335
REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells 331
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators 329
A CRISPR-strategy for the generation of a detectable fluorescent hESC reporter line (WAe009-A-37) for the subpallial determinant GSX2 327
Successful sequencing of Huntington’s disease CAG microsatellite orthologs from museum collection specimens 321
Nanoparticles for transport across the blood-brain barrier 315
Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1 314
Expression of the JAK and STAT superfamilies in human meningiomas 311
Brain-derived neurotrophic factor in patients with Huntington's disease 309
Normal Function of Huntingtin 303
hiPSCs for predictive modelling of neurodegenerative diseases : dreaming the possible 302
Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease 297
Neural stem cell systems: diversities and properties after transplantation in animal models of diseases 294
Huntingtin gene and its CAG repeats number in Primates 292
EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs 292
RUES2 hESCs exhibit MGE-biased neuronal differentiation and muHTT-dependent defective specification hinting at SP1 285
Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease : a cross-validation study in Q175 knock-in mice 283
Allele-specific silencing as treatment for gene duplication disorders : Proof-of-principle in autosomal dominant leukodystrophy 276
The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities 272
Wild-type huntingtin protects from apoptosis upstream of caspase-3 271
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell 269
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 267
In vitro-derived medium spiny neurons recapitulate human striatal development and complexity at single-cell resolution 266
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes 265
Huntingtin’s neuroprotective activity occurs via inhibition of pro-caspase 9 processing 261
A gene network regulating lysosomal biogenesis and function 260
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin 257
Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain 255
Activation of the JAK/STAT pathway leads to proliferation of ST14A central nervous system progenitor cells 251
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease 250
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF 250
Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data 248
Induced pluripotent stem cells from patients with Huntington’s disease: show CAG repeat-expansion-associated phenotypes 248
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice 248
An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population 247
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery 247
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 247
SREBP2 delivery to striatal astrocytes normalizes transcription of cholesterol biosynthesis genes and ameliorates pathological features in Huntington’s Disease 247
Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models 246
Evaluation of histone deacetylases as drug targets in Huntington's disease models : Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model 245
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target 244
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease 244
Human pluripotent stem cell differentiation into authentic striatal projection neurons 242
p66(ShcA) adaptor molecule accelerates ES cell neural induction 241
Dynamic and Cell-Specific DACH1 Expression in Human Neocortical and Striatal Development 240
Characterization, developmental expression and evolutionary features of the huntingtin gene in the amphioxus Branchiostoma floridae 239
Huntingtin gene evolution in Chordata and its peculiar features in the ascidian Ciona genus 239
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington disease 239
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 238
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease 236
Pitfalls in the detection of cholesterol in Huntington’s disease models 236
Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells 234
Molecular and functional definition of the developing human striatum 232
Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells 229
Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models 228
The function of the neuronal proteins shc and huntingtin in stem cells and neurons - Pharmacologic exploitation for human brain diseases 228
Murine SEL-1L, a gene implicated in the ERAD pathway, is expressed in mouse embryo stem cells and is controlled by mmu-miR-183 during neural stem cell differentiation 228
Normal huntingtin function: an alternative approach to Huntington's disease 227
Neural stem and progenitor cells: choosing the right Shc 227
Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease 223
Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death 223
Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease 221
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease 219
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons 219
Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells 218
Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation 216
From target identification to drug screening assays for neurodegenerative diseases 215
SEL-1L influences self-renewal in neural stem cells 215
Brain-derived neurotrophic factor in neurodegenerative diseases 213
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity 210
ACTIVATED ESTROGEN-RECEPTOR MEDIATES GROWTH ARREST AND DIFFERENTIATION OF A NEUROBLASTOMA CELL-LINE 209
Early and transient alteration of adenosine A(2A) receptor signaling in a mouse model of Huntington disease 207
Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin 207
Huntingtin gene CAG repeat size affects autism risk: Family-based and case–control association study 207
A DNA transposon-based approach to functional screening in neural stem cells 206
ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration 205
A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model 198
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntingtons disease 197
Huntington’s disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids 196
C-FOS INDUCTION BY ESTROGEN IN SPECIFIC RAT-BRAIN AREAS 195
Modeling human telencephalic development and autism-associated SHANK3 deficiency using organoids generated from single neural rosettes 194
Neural stem cell systems : physiological players or in vitro entities? 194
Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway 194
Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages 193
Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis 192
Neural stem cells engrafted in the adult brain fuse with endogenous neurons 191
Totale 29.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021813 0 0 0 0 0 0 0 0 0 0 603 210
2021/20223.534 193 143 135 235 348 254 325 269 369 352 309 602
2022/20234.307 630 467 384 523 426 684 136 293 390 89 181 104
2023/20243.090 113 193 664 197 585 105 144 193 98 190 253 355
2024/20256.159 268 545 196 601 473 302 375 697 345 578 525 1.254
2025/202611.857 1.061 784 1.212 936 1.278 829 1.858 648 1.497 846 908 0
Totale 45.068